Evidence map›Paper›PMID 34716371›Full record

ArticleScientific reports2021

Hypothalamic administration of sargahydroquinoic acid elevates peripheral thermogenic signaling and ameliorates high fat diet-induced obesity through the sympathetic nervous system.

Doyeon Kim, Yuna Lee, Hyeung-Rak Kim, Yeo Jin Park, Hongik Hwang, Hyewhon Rhim, Taek Kang, Chun Whan Choi, Bonggi Lee, Min Soo Kim

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Doyeon Kim *Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Yuna Lee *Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Hyeung-Rak KimDepartment of Food Science and Nutrition, Pukyong National University, Busan, 48513, Republic of Korea.
Yeo Jin ParkKorea Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu, 41062, Republic of Korea.
Hongik HwangBrain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Hyewhon RhimBrain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Taek KangBrain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Chun Whan ChoiNatural Product Research Team, Gyeonggi Biocenter, Gyeonggido Business and Science Accelerator, Suwon, Gyeonggi-Do, 16229, Republic of Korea.
Bonggi LeeDepartment of Food Science and Nutrition, Pukyong National University, Busan, 48513, Republic of Korea. bong3257@pknu.ac.kr.
Min Soo KimBrain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea. minsoo.kim@kist.re.kr.
Bio-Medical Science (South Korea) · KRKorea Institute of Science and Technology · KRKorean Association Of Science and Technology Studies · KRPukyong National University · KRKorea Institute of Brain Science · KRKorea University of Science and Technology · KR

Funding

National Research Foundation of Korea NRF-2020M3A9D8039920National Research Foundation of Korea NRF-2020R1A2C2006436
6 · The paper itself

Abstract

Sargassum serratifolium (C. Agardh) C.Agardh, a marine brown alga, has been consumed as a food and traditional medicine in Asia. A previous study showed that the meroterpenoid-rich fraction of an ethanolic extract of S. serratifolium (MES) induced adipose tissue browning and suppressed diet-induced obesity and metabolic syndrome when orally supplemented. Sargahydroquinoic acid (SHQA) is a major component of MES. However, it is unclear whether SHQA regulates energy homeostasis through the central nervous system. To examine this, SHQA was administrated through the third ventricle in the hypothalamus in high-fat diet-fed C57BL/6 mice and investigated its effects on energy homeostasis. Chronic administration of SHQA into the brain reduced body weight without a change in food intake and improved metabolic syndrome-related phenotypes. Cold experiments and biochemical analyses indicated that SHQA elevated thermogenic signaling pathways, as evidenced by an increase in body temperature and UCP1 signaling in white and brown adipose tissues. Peripheral denervation experiments using 6-OHDA indicated that the SHQA-induced anti-obesity effect is mediated by the activation of the sympathetic nervous system, possibly by regulating genes associated with sympathetic outflow and GABA signaling pathways. In conclusion, hypothalamic injection of SHQA elevates peripheral thermogenic signaling and ameliorates diet-induced obesity.

Indexed as

Adipose TissueAlkenesAnimalsBenzoquinonesDiet, High-FatHypothalamusMaleMetabolic SyndromeMiceMice, Inbred C57BLObesitySympathetic Nervous SystemThermogenesisAlkenesBenzoquinonessargahydroquinoic acid

Identifiers

PMID34716371
PMCPMC8556287
OpenAlexW3209143057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.